InvestorsHub Logo
Followers 21
Posts 1025
Boards Moderated 0
Alias Born 04/07/2008

Re: None

Thursday, 10/08/2020 4:57:48 AM

Thursday, October 08, 2020 4:57:48 AM

Post# of 2026
Nice to see the news on the Psoriasis indication. And the dropping of a group should reduce the costs a bit going forwards.

Acrobat trial news is disappointing of course, this could have been a wonderful safe alternative to methotrexate. But does reduce costs too going forwards.

PS there is something that I haven't been clear on for a while regards CANF Phase III trials. Are they pivotal trials or not? As in will they need to run another Phase III trial after this one? My feeling is that they will need to, but I've not found concrete information about this clarification as yet.

Would anyone happen to be able to shed light on this?

TIA
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CANF News